Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008-Reference-Cited by-同舟云学术

Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008

Published:2018-11-18 Issue:3 Volume:184 Page:405-417
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Højfeldt Sofie G.¹^ORCID,Wolthers Benjamin O.²^ORCID,Tulstrup Morten²^ORCID,Abrahamsson Jonas³,Gupta Ramneek⁴,Harila-Saari Arja⁵,Heyman Mats⁶,Henriksen Louise T.¹^ORCID,Jónsson Òlafur G.⁷,Lähteenmäki Päivi M.⁸,Lund Bendik⁹,Pruunsild Kaie¹⁰,Vaitkeviciene Goda¹¹,Schmiegelow Kjeld²,Albertsen Birgitte K.¹,

Affiliation:

1. Child and Adolescent Health; Aarhus University Hospital; Aarhus Denmark

2. Department of Paediatrics and Adolescent Medicine; University Hospital Rigshospitalet; Copenhagen Denmark

3. Department of Paediatrics; Institution for Clinical Sciences; Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

4. Department of Bio- and Health Informatics; Technical University of Denmark; Kongens Lyngby Denmark

5. Department of Women's and Children's health; Uppsala University; Uppsala Sweden

6. Department of Women's and Children's health; Childhood Cancer Research Unit; Karolinska University Hospital and Karolinska Institute; Stockholm Sweden

7. Children's Hospital; Landspitali University Hospital; Reykjavik Iceland

8. Department of Paediatric and Adolescent Medicine; Turku University Hospital and Turku University; Turku Finland

9. Department of Paediatrics; St. Olavs Hospital; Trondheim Norway

10. Department of Oncology and Haematology; University Children's Hospital; Tallinn Estonia

11. Clinic of Children's Diseases; Faculty of Medicine; Vilnius University; Vilnius Lithuania

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15660/fullpdf

Reference53 articles.

1. Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration;Albertsen;Cancer Chemotherapy and Pharmacology,2001

2. Data quality control in genetic case-control association studies;Anderson;Nature Protocols,2010

3. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients;Armstrong;Cancer,2007

4. Immunology of infusion reactions in the treatment of patients with acute lymphoblastic leukemia;Asselin;Future Oncology,2016

5. In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase;Asselin;Cancer Research,1989

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences;Pharmaceutics;2024-08-28

2. Asparaginase-associated Pancreatitis Complicated by Pancreatic Fluid Collection Treated with Endoscopic Cistogastrostomy in Pediatric Acute Lymphoblastic Leukemia: A Case Report and Systematic Review of the Literature.;Clinical Hematology International;2023-12-20

3. A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition;Malaysian Journal of Medical Sciences;2023-10-30

4. The efficacy and toxicity of L-asparaginase in the treatment of acute lymphoblastic leukemia in children;Pediatric Hematology/Oncology and Immunopathology;2023-10-03

5. Evaluating the Frequencies of CNOT3, GRIA1, NFATC2, and PNPLA3 Variant Alleles and Their Association with L-Asparaginase Hypersensitivity in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia;The Application of Clinical Genetics;2023-08